Journey II BCS
Device
Smith & Nephew, Inc.
Total Payments
$11.7M
Transactions
2,681
Doctors
721
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $4.4M | 1,238 | 432 |
| 2018 | $3.3M | 810 | 205 |
| 2017 | $4.0M | 633 | 242 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $8.0M | 117 | 68.2% |
| Unspecified | $2.3M | 200 | 19.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $798,584 | 149 | 6.8% |
| Travel and Lodging | $316,987 | 723 | 2.7% |
| Consulting Fee | $177,795 | 61 | 1.5% |
| Food and Beverage | $90,850 | 1,414 | 0.8% |
| Space rental or facility fees (teaching hospital only) | $26,173 | 15 | 0.2% |
| Education | $275.78 | 2 | 0.0% |
Payments by Type
General
$9.4M
2,481 transactions
Research
$2.3M
200 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study | Smith & Nephew, Inc. | $548,857 | 0 |
| In Vivo Kinematic Analysis of Cruciate Retaining, Posterior Cruciate Substituting and ACL-PCL Retaining Bi-Cruciate Total Knee Arthroplasty | Smith+Nephew, Inc. | $456,470 | 0 |
| Safety and Performance of Journey II BCS Total Knee System. A Retrospecitve, Multicenter Study | Smith & Nephew, Inc. | $259,829 | 0 |
| A Retro-Prospective, Non-randomized, Consecutive Series, SIngle Cohort, Multicenter Adaptive Design Study to Evaluate the Outcomes of Total Knee Arthroplasty TKA Using JOURNEY II BCS Total Knee System The NIMBLE study | Smith & Nephew, Inc. | $258,251 | 0 |
| Wellframe Validation | Smith+Nephew, Inc. | $206,117 | 0 |
| In Vivo Kinematic Analysis of Cruciate Retaining, Posterior Cruciate Substituting and ACL-PCL Retaining Bi-Cruciate Total Knee Arthroplasty | Smith & Nephew, Inc. | $201,764 | 0 |
| A Critical Assessment of the Factors That Promote or Limit the Return to Recreational, Work, and Physical Fitness Activities after Primary Total Knee Arthroplasty | Smith & Nephew, Inc. | $82,188 | 0 |
| Assessment of the JOURNEY II TKA to improve knee range of motion, patient reported outcomes, muscle strength, and joint kinematics | Smith & Nephew, Inc. | $81,056 | 0 |
| Wellframe Validation | Smith & Nephew, Inc. | $78,933 | 0 |
| Long Term Outcomes of Journey II BCS Constrained Liner | Smith & Nephew, Inc. | $50,397 | 0 |
| A Non-Randomized, Prospective Study of Short Term Outcomes following Total Knee Replacement with JOURNEY II BCS Total Knee System Compared to Other Posterior Stabilized Total Knee Systems in a Physical Therapy Setting | Smith & Nephew, Inc. | $30,807 | 0 |
| Journey 2 vs. Standard PS Knee | Smith & Nephew, Inc. | $28,583 | 0 |
| A Retro-Prospective, Non-randomized, Consecutive Series, SIngle Cohort, Multicenter Adaptive Design Study to Evaluate the Outcomes of Total Knee Arthroplasty TKA Using JOURNEY II BCS Total Knee System The NIMBLE study | Smith+Nephew, Inc. | $19,427 | 0 |
| Journey 2 vs. Standard PS Knee | Smith+Nephew, Inc. | $15,555 | 0 |
| Journey II BCS S&E (Nimble) | Smith & Nephew, Inc. | $324.00 | 0 |
Top Doctors Receiving Payments for Journey II BCS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Philadelphia, PA | $2.7M | 238 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Reno, NV | $2.5M | 89 |
| , M.D | Orthopaedic Surgery | New York, NY | $2.5M | 63 |
| , MD | Orthopaedic Surgery | Malvern, PA | $1.3M | 26 |
| , MD | Orthopaedic Surgery | New York, NY | $1.3M | 98 |
| Mark Snyder | — | Cincinnati, OH | $294,209 | 10 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Somerset, NJ | $151,922 | 180 |
| , M.D | Orthopaedic Surgery | Egg Harbor Township, NJ | $94,743 | 57 |
| , M.D | Orthopaedic Surgery | Lihue, HI | $58,949 | 27 |
| , M.D | Orthopaedic Surgery | Phoenix, AZ | $57,114 | 12 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Chicago, IL | $44,381 | 51 |
| , M.D | Orthopaedic Surgery | Lawrenceville, NJ | $42,618 | 26 |
| , M.D | Orthopaedic Surgery | Saint Louis, MO | $39,588 | 34 |
| , DO | Orthopaedic Surgery | Battle Creek, MI | $39,136 | 21 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | San Antonio, TX | $29,298 | 8 |
| , M.D | Pediatric Orthopaedic Surgery | La Jolla, CA | $28,594 | 33 |
| , M.D | Orthopaedic Surgery | New York, NY | $24,989 | 8 |
| , MD | Orthopaedic Surgery | Salisbury, NC | $24,517 | 23 |
| , MD | Orthopaedic Surgery | Knoxville, TN | $22,036 | 8 |
| , MD | Orthopaedic Surgery | Potomac, MD | $18,400 | 3 |
| , MD | Orthopaedic Surgery | Delray Beach, FL | $18,239 | 37 |
| , M.D., M.SC | General Acute Care Hospital | Orange, CA | $17,884 | 32 |
| , MD | Sports Medicine | Charlotte, NC | $17,336 | 24 |
| , M.D., PH.D | Adult Reconstructive Orthopaedic Surgery | Durham, NC | $15,373 | 14 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | San Diego, CA | $14,879 | 15 |
Ad
Manufacturing Companies
- Smith & Nephew, Inc. $7.3M
- Smith+Nephew, Inc. $4.4M
Product Information
- Type Device
- Total Payments $11.7M
- Total Doctors 721
- Transactions 2,681
About Journey II BCS
Journey II BCS is a device associated with $11.7M in payments to 721 healthcare providers, recorded across 2,681 transactions in the CMS Open Payments database. The primary manufacturer is Smith & Nephew, Inc..
Payment data is available from 2017 to 2019. In 2019, $4.4M was paid across 1,238 transactions to 432 doctors.
The most common payment nature for Journey II BCS is "Royalty or License" ($8.0M, 68.2% of total).
Journey II BCS is associated with 15 research studies, including "Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study" ($548,857).